Digitally quantified area of residual tumor after neoadjuvant chemotherapy in HER2-positive breast cancer. - Uematsu M; Nakajima H; Miyake H; Wakabayashi M; Funasaka C; Kondoh C; Harano K; Matsubara N; Hosono A; Naito Y; Sakamoto N; Kojima M; et al. (Breast cancer (Tokyo, Japan), 2025)